Message #5 From:
Stock News Bot Date: October 31, 2006 06:15:00 AM
CMPD News CompuMed to Present at Rodman & Renshaw Techvest 8th Annual Healthcare Conference on November 8, 2006
LOS ANGELES--(BUSINESS WIRE)--CompuMed, Inc. (OTCBB:CMPD) – a medical
informatics company leading the development of advanced imaging
technology for cost effective analysis and monitoring –
today announced that it will present at the Rodman & Renshaw Techvest
8th Annual Healthcare Conference, on Wednesday, November 8th at 8:50 AM
EST at the Palace Hotel in New York. CompuMed is among the select 300
emerging growth biotechnology companies scheduled to present at the
conference, which will unite such companies with institutional
investors, venture capitalists, senior corporate executives and experts
from the scientific and medical communities.
Jerry McLaughlin, CompuMed’s CEO, will outline
the Company’s growth strategy to position
itself as the leading provider of remote imaging analysis in cardiology
and radiology. The presentation will be webcast live and available for
90 days at http://www.wsw.com/webcast/rrshq10/cmpd.ob.
More information about the conference is available at www.rodmanandrenshaw.com/us06conference.
About CompuMed:
Founded in 1973, CompuMed, Inc. (OTCBB:CMPD) is leading the development
of advanced imaging and medical informatics solutions that provide cost
effective analysis and monitoring. The Company focuses on cardiovascular
and musculoskeletal diseases, as well as other diseases associated with
aging populations. Its unique expertise in telemonitoring, imaging and
analysis facilitates the development of new solutions and services
designed to improve healthcare provider workflow and patient care, while
reducing costs. The company's core products are the OsteoGram®
and CardioGram systems. The OsteoGram, which is cleared by the FDA for
commercial use, is an accurate and precise technology for low-cost
osteoporosis testing. The CardioGram system remotely interprets
electrocardiograms and is used by private practice, government and
corporate healthcare providers nationwide. The CardioGram has the
additional capability to automatically provide an over-read (i.e.,
follow-up review) by a cardiologist. CompuMed is headquartered in Los
Angeles. Visit CompuMed at www.compumed.net.
This news release contains forward-looking statements as defined by the
Private Securities Litigation Reform Act of 1995. Forward-looking
statements include statements concerning plans, objectives, goals,
strategies, future events or performance and underlying assumptions and
other statements that are other than statements of historical facts.
These statements are subject to uncertainties and risks including, but
not limited to, product and service demand and acceptance, changes in
technology, ability to raise capital, availability of appropriate
acquisition candidates and/or business partnerships, economic
conditions, impact of competition and pricing, capacity and supply
constraints or difficulties, government regulation and other risks
defined in this document. All such forward-looking statements whether
written or oral, and whether made by or on behalf of the Companies are
expressly qualified by these cautionary statements and any other
cautionary statements which may accompany the forward-looking
statements. In addition, the Company disclaims any obligation to update
any forward-looking statements to reflect events or circumstances after
the date hereof.
